Both the LEADER (liraglutide) and SUSTAIN-6 (subcutaneous semaglutide) trials reported significant reductions in the primary outcome (incidence of MACE)
Retrieved from Xie, W., Su, F., Wang, G., et al
Keeping a symptom diary, maintaining your current IBD medications without interruption, and scheduling colonoscopy or imaging if new symptoms emerge are essential safety steps
This is the piece women in their forties and fifties skip most often, usually because cardio feels more productive when the goal is weight loss and because lifting heavy feels like something other people do
Preclinical studies demonstrate potent NF-kB inhibition and IL-10 elevation at microgram-level doses
Semaglutide doses for weight loss and how to use it Wegovy dosing for weight management is available in .25-, .50, 1.0, 1.7, and 2.4-milligram doses